SEC Form 4 · accession 0001127602-16-069552
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terence M Berge
Officer — VP Corp. Treasurer
Period of report
Dec 8, 2016
Accepted (ET)
Dec 9, 2016 · 12:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 8, 2016 | M | 2,500 | $29.92 | A | 18,155 | D | |
| Common Stock | Dec 8, 2016 | F | 1,968 | $45.21 | D | 16,187 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $29.92 | Dec 8, 2016 | M | 2,500 | D | — | May 17, 2017 | Common Stock | 2,500 | 0 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.